Search Results : HIV

604 interactions found:

Novel Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
bleomycin hydrolase
Name2
cytochrome P450 family 2 subfamily C member 8
Pathway 1
  • Antigen processing: Ubiquitination & Proteasome degradation
Pathway 2
  • Xenobiotics
  • CYP2E1 reactions
  • Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
  • Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
  • Biosynthesis of maresin-like SPMs
  • Aspirin ADME
Drugs 1
Drugs 2
  • Isoniazid
  • Palmitic Acid
  • (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
CF transmembrane conductance regulator
Name2
dedicator of cytokinesis 10
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RAC3 GTPase cycle
  • Factors involved in megakaryocyte development and platelet production
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Novel
Symbols
Name 1
CF transmembrane conductance regulator
Name2
vacuolar protein sorting 4 homolog B
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
  • Budding and maturation of HIV virion
  • Endosomal Sorting Complex Required For Transport (ESCRT)
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Novel
Symbols
Name 1
CF transmembrane conductance regulator
Name2
small integral membrane protein 21
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Novel
Name 1
CF transmembrane conductance regulator
Name2
HIV-1 Tat interactive protein 2
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
  • Polyethylene glycol 400
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Novel
Name 1
minichromosome maintenance complex component 3
Name2
SPT16 homolog, facilitates chromatin remodeling subunit
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • Regulation of TP53 Activity through Phosphorylation
  • RNA Polymerase II Transcription Elongation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
protein kinase AMP-activated non-catalytic subunit beta 2
Name2
interleukin 37
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Macroautophagy
  • AMPK inhibits chREBP transcriptional activation activity
  • AMPK inhibits chREBP transcriptional activation activity
  • Carnitine shuttle
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Regulation of TP53 Activity through Phosphorylation
  • Lipophagy
  • Activation of AMPK downstream of NMDARs
  • AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)
Pathway 2
  • Interleukin-37 signaling
  • Interleukin-18 signaling
Drugs 1
  • Adenosine phosphate
  • Acetylsalicylic acid
  • Fostamatinib
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
protein kinase AMP-activated non-catalytic subunit beta 2
Name2
ZFP90 zinc finger protein
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Macroautophagy
  • AMPK inhibits chREBP transcriptional activation activity
  • AMPK inhibits chREBP transcriptional activation activity
  • Carnitine shuttle
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Regulation of TP53 Activity through Phosphorylation
  • Lipophagy
  • Activation of AMPK downstream of NMDARs
  • AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)
Pathway 2
  • Generic Transcription Pathway
Drugs 1
  • Adenosine phosphate
  • Acetylsalicylic acid
  • Fostamatinib
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
ring finger protein 4
Name2
absent in melanoma 2
Pathway 1
  • Processing of DNA double-strand break ends
  • Antigen processing: Ubiquitination & Proteasome degradation
Pathway 2
  • Cytosolic sensors of pathogen-associated DNA
  • The AIM2 inflammasome
  • The AIM2 inflammasome
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
cell division cycle 5 like
Name2
EMI domain containing 1
Pathway 1
  • mRNA Splicing - Major Pathway
Pathway 2
  • O-linked glycosylation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
thyroid hormone receptor interactor 6
Name2
nucleoporin 210
Pathway 1
Pathway 2
  • ISG15 antiviral mechanism
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Rev-mediated nuclear export of HIV RNA
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Viral Messenger RNA Synthesis
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear import of Rev protein
  • Vpr-mediated nuclear import of PICs
  • IPs transport between nucleus and cytosol
  • IP3 and IP4 transport between cytosol and nucleus
  • IP6 and IP7 transport between cytosol and nucleus
  • snRNP Assembly
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of ubiquitinylation proteins
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of HSF1-mediated heat shock response
  • SUMOylation of SUMOylation proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • Transcriptional regulation by small RNAs
  • Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
  • tRNA processing in the nucleus
  • HCMV Early Events
  • HCMV Late Events
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
toll like receptor 4
Name2
ring finger protein 216
Pathway 1
  • ER-Phagosome pathway
  • Caspase activation via Death Receptors in the presence of ligand
  • Toll Like Receptor 4 (TLR4) Cascade
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • MyD88-independent TLR4 cascade
  • TRIF-mediated programmed cell death
  • MyD88 deficiency (TLR2/4)
  • IRAK4 deficiency (TLR2/4)
  • Regulation of TLR by endogenous ligand
  • Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
  • IKK complex recruitment mediated by RIP1
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • Heme signaling
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Respiratory syncytial virus (RSV) attachment and entry
  • Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7
  • RSV-host interactions
Pathway 2
  • Negative regulators of DDX58/IFIH1 signaling
Drugs 1
  • Cyclobenzaprine
  • Naloxone
  • (R)-3-hydroxytetradecanoic acid
  • Lauric acid
  • Eritoran
  • Golotimod
  • E5531
  • Myristic acid
  • Papain
  • Mifamurtide
Drugs 2
Diseases 1
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
Diseases 2
Novel
Novel
Symbols
Name 1
SMAD family member 3
Name2
exportin 6
Pathway 1
  • Signaling by NODAL
  • Signaling by NODAL
  • Signaling by Activin
  • Signaling by Activin
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • SMAD4 MH2 Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Ub-specific processing proteases
  • RUNX3 regulates CDKN1A transcription
  • RUNX3 regulates BCL2L11 (BIM) transcription
  • Interleukin-37 signaling
  • NOTCH4 Intracellular Domain Regulates Transcription
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • FOXO-mediated transcription of cell cycle genes
  • FOXO-mediated transcription of cell cycle genes
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • Germ layer formation at gastrulation
  • Formation of axial mesoderm
  • Formation of definitive endoderm
  • Formation of definitive endoderm
  • TGFBR3 expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
cyclin T2
Name2
HEXIM P-TEFb complex subunit 1
Pathway 1
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase II Transcription Elongation
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
zinc finger and BTB domain containing 17
Name2
zinc finger and BTB domain containing 7C
Pathway 1
  • XBP1(S) activates chaperone genes
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
target of myb1 membrane trafficking protein
Name2
single stranded DNA binding protein 2
Pathway 1
  • Neutrophil degranulation
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
histone deacetylase 2
Name2
REST corepressor 1
Pathway 1
  • p75NTR negatively regulates cell cycle via SC1
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • HDACs deacetylate histones
  • Notch-HLH transcription pathway
  • ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
  • NoRC negatively regulates rRNA expression
  • SUMOylation of chromatin organization proteins
  • Regulation of TP53 Activity through Acetylation
  • RNA Polymerase I Transcription Initiation
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Regulation of MECP2 expression and activity
  • MECP2 regulates neuronal receptors and channels
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Potential therapeutics for SARS
  • STAT3 nuclear events downstream of ALK signaling
  • Negative Regulation of CDH1 Gene Transcription
  • Factors involved in megakaryocyte development and platelet production
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
  • Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
Pathway 2
  • HDACs deacetylate histones
  • Regulation of PTEN gene transcription
  • Potential therapeutics for SARS
  • Factors involved in megakaryocyte development and platelet production
Drugs 1
  • Pravastatin
  • Lovastatin
  • Theophylline
  • Valproic acid
  • Valproic acid
  • Simvastatin
  • Atorvastatin
  • Fluvastatin
  • Aminophylline
  • Decitabine
  • Oxtriphylline
  • Vorinostat
  • Vorinostat
  • Belinostat
  • Pracinostat
  • Romidepsin
  • Romidepsin
  • Panobinostat
  • Phenylbutyric acid
  • Tixocortol
  • Mocetinostat
  • Entinostat
  • Abexinostat
  • Givinostat
  • Pyroxamide
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Name 1
fasciculation and elongation protein zeta 1
Name2
HIV-1 Tat specific factor 1
Pathway 1
Pathway 2
  • mRNA Splicing - Major Pathway
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Novel
Symbols
Name 1
heat shock protein family B (small) member 1
Name2
nuclear VCP like
Pathway 1
  • VEGFA-VEGFR2 Pathway
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • MAPK6/MAPK4 signaling
  • Extra-nuclear estrogen signaling
Pathway 2
Drugs 1
  • Apatorsen
  • Artenimol
  • Phenethyl Isothiocyanate
Drugs 2
Diseases 1
  • Distal hereditary motor neuropathies (dHMN)
Diseases 2
Novel
Novel
Symbols
Name 1
heat shock protein family B (small) member 1
Name2
protein tyrosine phosphatase non-receptor type 3
Pathway 1
  • VEGFA-VEGFR2 Pathway
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • MAPK6/MAPK4 signaling
  • Extra-nuclear estrogen signaling
Pathway 2
  • EGFR downregulation
  • Negative regulation of MAPK pathway
Drugs 1
  • Apatorsen
  • Artenimol
  • Phenethyl Isothiocyanate
Drugs 2
Diseases 1
  • Distal hereditary motor neuropathies (dHMN)
Diseases 2
Novel
Symbols
Name 1
bleomycin hydrolase
Name2
cytochrome P450 family 2 subfamily C member 8
Pathway 1
  • Antigen processing: Ubiquitination & Proteasome degradation
Pathway 2
  • Xenobiotics
  • CYP2E1 reactions
  • Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
  • Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
  • Biosynthesis of maresin-like SPMs
  • Aspirin ADME
Drugs 1
Drugs 2
  • Isoniazid
  • Palmitic Acid
  • (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE
Diseases 1
Diseases 2
Novel
Symbols
Name 1
CF transmembrane conductance regulator
Name2
dedicator of cytokinesis 10
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
  • CDC42 GTPase cycle
  • RAC1 GTPase cycle
  • RAC2 GTPase cycle
  • RAC3 GTPase cycle
  • Factors involved in megakaryocyte development and platelet production
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Symbols
Name 1
CF transmembrane conductance regulator
Name2
vacuolar protein sorting 4 homolog B
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
  • Budding and maturation of HIV virion
  • Endosomal Sorting Complex Required For Transport (ESCRT)
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Symbols
Name 1
CF transmembrane conductance regulator
Name2
small integral membrane protein 21
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Name 1
CF transmembrane conductance regulator
Name2
HIV-1 Tat interactive protein 2
Pathway 1
  • ABC-family proteins mediated transport
  • RHO GTPases regulate CFTR trafficking
  • Defective CFTR causes cystic fibrosis
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • RHOQ GTPase cycle
  • Chaperone Mediated Autophagy
  • Late endosomal microautophagy
  • Aggrephagy
  • Aggrephagy
  • Developmental Lineage of Pancreatic Ductal Cells
Pathway 2
Drugs 1
  • ATP
  • Bumetanide
  • Glyburide
  • Ibuprofen
  • Genistein
  • Colforsin
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • Dexfosfoserine
  • Crofelemer
  • Lonidamine
  • Ivacaftor
  • Dexibuprofen
  • Lumacaftor
  • Tezacaftor
  • Elexacaftor
Drugs 2
  • Polyethylene glycol 400
Diseases 1
  • Hereditary pancreatitis; Hereditary chronic pancreatitis
  • Cystic fibrosis (CF)
  • Congenital bilateral absence of vas deferens
Diseases 2
Novel
Name 1
minichromosome maintenance complex component 3
Name2
SPT16 homolog, facilitates chromatin remodeling subunit
Pathway 1
  • Activation of ATR in response to replication stress
  • Unwinding of DNA
  • Assembly of the pre-replicative complex
  • Assembly of the pre-replicative complex
  • Orc1 removal from chromatin
  • Activation of the pre-replicative complex
  • Switching of origins to a post-replicative state
Pathway 2
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • Pausing and recovery of Tat-mediated HIV elongation
  • Tat-mediated HIV elongation arrest and recovery
  • Tat-mediated elongation of the HIV-1 transcript
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • Regulation of TP53 Activity through Phosphorylation
  • RNA Polymerase II Transcription Elongation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
protein kinase AMP-activated non-catalytic subunit beta 2
Name2
interleukin 37
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Macroautophagy
  • AMPK inhibits chREBP transcriptional activation activity
  • AMPK inhibits chREBP transcriptional activation activity
  • Carnitine shuttle
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Regulation of TP53 Activity through Phosphorylation
  • Lipophagy
  • Activation of AMPK downstream of NMDARs
  • AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)
Pathway 2
  • Interleukin-37 signaling
  • Interleukin-18 signaling
Drugs 1
  • Adenosine phosphate
  • Acetylsalicylic acid
  • Fostamatinib
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
protein kinase AMP-activated non-catalytic subunit beta 2
Name2
ZFP90 zinc finger protein
Pathway 1
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Macroautophagy
  • AMPK inhibits chREBP transcriptional activation activity
  • AMPK inhibits chREBP transcriptional activation activity
  • Carnitine shuttle
  • Activation of PPARGC1A (PGC-1alpha) by phosphorylation
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • TP53 Regulates Metabolic Genes
  • Regulation of TP53 Activity through Phosphorylation
  • Lipophagy
  • Activation of AMPK downstream of NMDARs
  • AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274)
Pathway 2
  • Generic Transcription Pathway
Drugs 1
  • Adenosine phosphate
  • Acetylsalicylic acid
  • Fostamatinib
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
ring finger protein 4
Name2
absent in melanoma 2
Pathway 1
  • Processing of DNA double-strand break ends
  • Antigen processing: Ubiquitination & Proteasome degradation
Pathway 2
  • Cytosolic sensors of pathogen-associated DNA
  • The AIM2 inflammasome
  • The AIM2 inflammasome
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
cell division cycle 5 like
Name2
EMI domain containing 1
Pathway 1
  • mRNA Splicing - Major Pathway
Pathway 2
  • O-linked glycosylation
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
thyroid hormone receptor interactor 6
Name2
nucleoporin 210
Pathway 1
Pathway 2
  • ISG15 antiviral mechanism
  • Transport of the SLBP independent Mature mRNA
  • Transport of the SLBP Dependant Mature mRNA
  • Transport of Mature mRNA Derived from an Intronless Transcript
  • Transport of Mature mRNA derived from an Intron-Containing Transcript
  • Rev-mediated nuclear export of HIV RNA
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Viral Messenger RNA Synthesis
  • NEP/NS2 Interacts with the Cellular Export Machinery
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear import of Rev protein
  • Vpr-mediated nuclear import of PICs
  • IPs transport between nucleus and cytosol
  • IP3 and IP4 transport between cytosol and nucleus
  • IP6 and IP7 transport between cytosol and nucleus
  • snRNP Assembly
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of ubiquitinylation proteins
  • Nuclear Pore Complex (NPC) Disassembly
  • Regulation of HSF1-mediated heat shock response
  • SUMOylation of SUMOylation proteins
  • SUMOylation of chromatin organization proteins
  • SUMOylation of RNA binding proteins
  • SUMOylation of DNA replication proteins
  • SUMOylation of DNA replication proteins
  • Transcriptional regulation by small RNAs
  • Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
  • tRNA processing in the nucleus
  • HCMV Early Events
  • HCMV Late Events
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
toll like receptor 4
Name2
ring finger protein 216
Pathway 1
  • ER-Phagosome pathway
  • Caspase activation via Death Receptors in the presence of ligand
  • Toll Like Receptor 4 (TLR4) Cascade
  • MyD88:MAL(TIRAP) cascade initiated on plasma membrane
  • MyD88-independent TLR4 cascade
  • TRIF-mediated programmed cell death
  • MyD88 deficiency (TLR2/4)
  • IRAK4 deficiency (TLR2/4)
  • Regulation of TLR by endogenous ligand
  • Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE)
  • IKK complex recruitment mediated by RIP1
  • TRAF6-mediated induction of TAK1 complex within TLR4 complex
  • Heme signaling
  • IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
  • Respiratory syncytial virus (RSV) attachment and entry
  • Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7
  • RSV-host interactions
Pathway 2
  • Negative regulators of DDX58/IFIH1 signaling
Drugs 1
  • Cyclobenzaprine
  • Naloxone
  • (R)-3-hydroxytetradecanoic acid
  • Lauric acid
  • Eritoran
  • Golotimod
  • E5531
  • Myristic acid
  • Papain
  • Mifamurtide
Drugs 2
Diseases 1
  • Macular degeneration, including: Age-related macular degeneration (ARMD); Patterned dystrophy of retinal pigment epithelium (PDREP); Retinal macular dystrophy 2 (MCDR2); X-linked atrophic macular degeneration (MDXLA)
Diseases 2
Novel
Symbols
Name 1
SMAD family member 3
Name2
exportin 6
Pathway 1
  • Signaling by NODAL
  • Signaling by NODAL
  • Signaling by Activin
  • Signaling by Activin
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • SMAD4 MH2 Domain Mutants in Cancer
  • SMAD2/3 MH2 Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • Ub-specific processing proteases
  • RUNX3 regulates CDKN1A transcription
  • RUNX3 regulates BCL2L11 (BIM) transcription
  • Interleukin-37 signaling
  • NOTCH4 Intracellular Domain Regulates Transcription
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • FOXO-mediated transcription of cell cycle genes
  • FOXO-mediated transcription of cell cycle genes
  • SARS-CoV-1 targets host intracellular signalling and regulatory pathways
  • Germ layer formation at gastrulation
  • Formation of axial mesoderm
  • Formation of definitive endoderm
  • Formation of definitive endoderm
  • TGFBR3 expression
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
cyclin T2
Name2
HEXIM P-TEFb complex subunit 1
Pathway 1
  • Formation of RNA Pol II elongation complex
  • Formation of HIV elongation complex in the absence of HIV Tat
  • HIV elongation arrest and recovery
  • Pausing and recovery of HIV elongation
  • SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
  • RNA Polymerase II Pre-transcription Events
  • TP53 Regulates Transcription of DNA Repair Genes
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
  • RNA Polymerase II Transcription Elongation
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
zinc finger and BTB domain containing 17
Name2
zinc finger and BTB domain containing 7C
Pathway 1
  • XBP1(S) activates chaperone genes
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
target of myb1 membrane trafficking protein
Name2
single stranded DNA binding protein 2
Pathway 1
  • Neutrophil degranulation
Pathway 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
histone deacetylase 2
Name2
REST corepressor 1
Pathway 1
  • p75NTR negatively regulates cell cycle via SC1
  • NOTCH1 Intracellular Domain Regulates Transcription
  • Constitutive Signaling by NOTCH1 PEST Domain Mutants
  • Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
  • HDACs deacetylate histones
  • Notch-HLH transcription pathway
  • ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
  • NoRC negatively regulates rRNA expression
  • SUMOylation of chromatin organization proteins
  • Regulation of TP53 Activity through Acetylation
  • RNA Polymerase I Transcription Initiation
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Regulation of MECP2 expression and activity
  • MECP2 regulates neuronal receptors and channels
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
  • Potential therapeutics for SARS
  • STAT3 nuclear events downstream of ALK signaling
  • Negative Regulation of CDH1 Gene Transcription
  • Factors involved in megakaryocyte development and platelet production
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Transcriptional regulation of brown and beige adipocyte differentiation by EBF2
  • Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)
Pathway 2
  • HDACs deacetylate histones
  • Regulation of PTEN gene transcription
  • Potential therapeutics for SARS
  • Factors involved in megakaryocyte development and platelet production
Drugs 1
  • Pravastatin
  • Lovastatin
  • Theophylline
  • Valproic acid
  • Valproic acid
  • Simvastatin
  • Atorvastatin
  • Fluvastatin
  • Aminophylline
  • Decitabine
  • Oxtriphylline
  • Vorinostat
  • Vorinostat
  • Belinostat
  • Pracinostat
  • Romidepsin
  • Romidepsin
  • Panobinostat
  • Phenylbutyric acid
  • Tixocortol
  • Mocetinostat
  • Entinostat
  • Abexinostat
  • Givinostat
  • Pyroxamide
Drugs 2
Diseases 1
Diseases 2
Novel
Name 1
fasciculation and elongation protein zeta 1
Name2
HIV-1 Tat specific factor 1
Pathway 1
Pathway 2
  • mRNA Splicing - Major Pathway
Drugs 1
Drugs 2
Diseases 1
Diseases 2
Novel
Symbols
Name 1
heat shock protein family B (small) member 1
Name2
nuclear VCP like
Pathway 1
  • VEGFA-VEGFR2 Pathway
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • MAPK6/MAPK4 signaling
  • Extra-nuclear estrogen signaling
Pathway 2
Drugs 1
  • Apatorsen
  • Artenimol
  • Phenethyl Isothiocyanate
Drugs 2
Diseases 1
  • Distal hereditary motor neuropathies (dHMN)
Diseases 2
Novel
Symbols
Name 1
heat shock protein family B (small) member 1
Name2
protein tyrosine phosphatase non-receptor type 3
Pathway 1
  • VEGFA-VEGFR2 Pathway
  • AUF1 (hnRNP D0) binds and destabilizes mRNA
  • MAPK6/MAPK4 signaling
  • Extra-nuclear estrogen signaling
Pathway 2
  • EGFR downregulation
  • Negative regulation of MAPK pathway
Drugs 1
  • Apatorsen
  • Artenimol
  • Phenethyl Isothiocyanate
Drugs 2
Diseases 1
  • Distal hereditary motor neuropathies (dHMN)
Diseases 2

Page 19 out of 31 pages

© Madhavi K. Ganapathiraju 2012-2025